International Growth Concentrated Strategy

Strategy Objective

A non-US all-cap growth equity strategy that invests in a concentrated portfolio of common stocks of growth companies based outside the United States and seeks to outperform the MSCI ACWI ex USA Index over a full market cycle.

Key Differentiators

  • In-depth capital structure analysis
  • Rigorous top-down and fundamental research
  • High active share, high relative growth focus
  • Team approach to management

Strategy Details

As of 6/30/22
Inception Date: 12/01/13
Strategy Assets*: $65.2 M
Benchmark: MSCI ACWI ex USA Index

*Strategy Assets reflect all assets that are currently being managed (collectively) under the strategy, which may contain multiple performance composites.


Sector Weightings

As of 6/30/22
Sector % of Assets MSCI ACWI ex USA Index Under/Overweight %
Industrials 15.9% 11.8%
Health Care 15.9% 9.8%
Information Technology 15.8% 11.0%
Financials 13.7% 20.3%
Consumer Discretionary 11.6% 11.7%
Energy 8.8% 6.0%
Consumer Staples 7.8% 8.9%
Communication Services 6.3% 6.5%
Materials 4.2% 8.0%
Utilities 0.0% 3.4%
Real Estate 0.0% 2.5%
Other 0.0% 0.0%

Representative Portfolio Ten Largest Holdings

As of 6/30/22
Company Country Sector %
Novo Nordisk, A/S - Class B Denmark Health Care 5.5
AstraZeneca, PLC United Kingdom Health Care 4.1
AIA Group, Ltd. Hong Kong Financials 4.0
ASML Holding, NV Netherlands Information Technology 3.9
Thales, Sa France Industrials 3.9
Taiwan Semiconductor Mfg Taiwan Information Technology 3.7
Tencent Holdings, Ltd. China Communication Services 3.6
Rheinmetall, AG Germany Industrials 3.3
Canadian Natural Resources, Ltd. Canada Energy 3.2
Airbus, SE France Industrials 3.2


As of 6/30/22
Name Calamos Portfolio MSCI ACWI ex USA Index
Number of Holdings 36 2,263
Portfolio Turnover (12 months) 32.2% N/A
Median Market Cap $64.9 B $8.6 B
Weighted Avg. Market Cap $128.6 B $81.4 B
ROIC 18.1% 14.6%
Debt/Capital 33.3% 33.1%
PEG Ratio 1.4x 1.6x


Annualized Total Returns

As of 6/30/22
Name 1-Year 3-Year 5-Year Since Inception (12/13)
International Growth Concentrated (Gross) -24.05% 11.77% 9.88% 7.02%
International Growth Concentrated (Net) -24.62% 10.89% 8.98% 6.06%
MSCI ACWI ex USA Index -19.01% 1.81% 2.97% 2.96%

Calendar Year Returns

As of 6/30/22
Name Qtr ending Jun 22 YTD 2022 2021 2020 2019 2018 2017 2016 2015 2014 12/1/13 - 12/31/13
International Growth Concentrated (Gross) -16.97% -24.74% 12.70% 51.22% 32.49% -19.56% 37.17% -5.82% 6.03% -7.42% 3.29%
International Growth Concentrated (Net) -17.13% -25.03% 11.86% 50.01% 31.39% -20.26% 35.82% -6.75% 4.99% -8.33% 3.20%
MSCI ACWI ex USA Index -13.54% -18.15% 8.29% 11.13% 22.13% -13.78% 27.76% 5.00% -5.25% -3.44% 0.90%

Past performance does not guarantee or indicate future results. Portfolios are managed according to their respective strategies which may differ significantly in terms of security holdings, industry weightings, and asset allocation from those of the benchmark(s). Portfolio performance, characteristics and volatility may differ from the benchmark(s) shown.

Returns and Risk/Reward statistics presented reflect the Calamos International Growth Concentrated Composite which is an actively managed composite primarily investing in a concentrated portfolio of common stocks issued by companies outside the United States. The Composite was created December 13, 2013 calculated with an inception date of December 1, 2013 and includes all fully discretionary fee paying accounts, including those no longer with the Firm.

Unmanaged index returns, unlike fund returns, do not reflect fees, expenses or sales charges. Investors cannot invest directly in an index.

The MSCI ACWI ex USA Index represents performance of large- and mid-cap stocks across developed and emerging markets excluding the United States.

Fees include the investment advisory fee charge by Calamos Advisors LLC. Returns greater than 12 months are annualized. Chart Data Sources: Calamos Advisors LLC.

Average annual total return measures net investment income and capital gain or loss from portfolio investments as an annualized average. All performance shown assumes reinvestment of dividends and capital gains distributions.


Risk/Reward Since Inception

As of 6/30/22
Name Calamos International Growth Concentrated Composite MSCI ACWI ex USA Index
Alpha 4.11% N/A
Beta 1.03 1.00
Annualized Standard Deviation 16.21% 14.21%
Upside Semivariance 13.44% 8.73%
Downside Semivariance 8.71% 8.04%
Sharpe Ratio 0.39 0.16
Information Ratio 0.59 N/A

Since Inception Up/Down Capture Vs. MSCI ACWI ex USA Index

As of 6/30/22

Vehicles & Minimums

Vehicles and Minimums

Vehicle Minimum Availability
Separately Managed Accounts $25 million Available to new investors


PDF Thumb

Fact Sheet

The International Growth Concentrated Strategy fact sheet provides a snap shot of the investment team, the investment strategy, performance, composition, ratings and returns.

PDF Thumb

Performance Review

A discussion of the International Growth Concentrated Strategy’s performance versus a benchmark, positioning, related market commentary, and outlook.